🇺🇸 FDA
Pipeline program

Celestone Cronodose suspensión inyectable, Ropivacaína Altan 7,5 mg/ml solución inyectable EFG, PLATELET CONCENTRATE

SHIELD-PRP

Phase 3 small_molecule active

Quick answer

Celestone Cronodose suspensión inyectable, Ropivacaína Altan 7,5 mg/ml solución inyectable EFG, PLATELET CONCENTRATE for CHRONIC OMALGIA is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
CHRONIC OMALGIA
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials